| Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas RDA Weren, AR Mensenkamp, M Simons, A Eijkelenboom, AS Sie, ... Human mutation 38 (2), 226-235, 2017 | 76 | 2017 |
| Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition JR Vos, IE Fakkert, JA de Hullu, AM van Altena, AS Sie, H Ouchene, ... JNCI: Journal of the National Cancer Institute 112 (2), 161-169, 2020 | 63 | 2020 |
| More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling AS Sie, WAG van Zelst-Stams, L Spruijt, AR Mensenkamp, ... Familial cancer 13, 143-151, 2014 | 54 | 2014 |
| High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling AS Sie, L Spruijt, WAG van Zelst-Stams, AR Mensenkamp, ... Journal of genetic counseling 25, 504-514, 2016 | 40 | 2016 |
| Patient experiences with gene panels based on exome sequencing in clinical diagnostics: high acceptance and low distress AS Sie, JB Prins, WAG van Zelst‐Stams, JA Veltman, I Feenstra, ... Clinical Genetics, 2014 | 33 | 2014 |
| Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective AS Sie, AR Mensenkamp, EMM Adang, MJL Ligtenberg, N Hoogerbrugge Annals of oncology 25 (10), 2001-2007, 2014 | 31 | 2014 |
| Stopping ovarian cancer screening in BRCA1/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens CMG van Driel, GH de Bock, HJG Arts, AS Sie, H Hollema, JC Oosterwijk, ... Maturitas 80 (3), 318-322, 2015 | 26 | 2015 |
| Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress A Van Erkelens, AS Sie, P Manders, A Visser, LE Duijm, RM Mann, ... European Journal of Cancer 78, 45-52, 2017 | 22 | 2017 |
| Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes AS Sie, JB Prins, L Spruijt, CM Kets, N Hoogerbrugge Familial cancer 12, 675-682, 2013 | 19 | 2013 |
| Lifestyle risk factors for breast cancer in BRCA1/2-mutation carriers around childbearing age A Van Erkelens, L Derks, AS Sie, L Egbers, G Woldringh, JB Prins, ... Journal of Genetic Counseling 26, 785-791, 2017 | 18 | 2017 |
| DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct AS Sie, L Spruijt, WAG van Zelst-Stams, AR Mensenkamp, MJ Ligtenberg, ... BMC Women's Health 12, 1-7, 2012 | 15 | 2012 |
| An online self‐test added to colorectal cancer screening can increase the effectiveness of familial cancer risk assessment without increasing distress A Van Erkelens, AS Sie, MBW Spanier, M van Kouwen, A Visser, JB Prins, ... Colorectal Disease 20 (10), 897-904, 2018 | 6 | 2018 |
| Easy-to-use decision aids for improved cancer family history collection and use among oncology practices AS Sie, HG Brunner, N Hoogerbrugge | 6 | 2014 |
| Proffered papers and posters presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer—BRCA: Challenges and Opportunities: Presented by the … L Starita, M Islam, S Fields, J Parvin, J Shendure, J Vierstraete, A Willaert, ... Current Oncology (Toronto, Ont.) 23 (3), e284-e319, 2016 | | 2016 |
| Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective AS Sie, AR Mensenkamp, EM Adang, MJ Ligtenberg, N Hoogerbrugge Nederlands tijdschrift voor geneeskunde 158, A8449, 2015 | | 2015 |
| Innovations in genetic testing and counseling: Patient experiences AS Sie Radboudumc, 2015 | | 2015 |
| Diagnostiek Lynch-syndroom bij colorectaal carcinoom AS Sie, AR Mensenkamp, EMM Adang, MJL Ligtenberg, N Hoogerbrugge Ned Tijdschr Geneeskd. 2014 (158), A8449, 2014 | | 2014 |
| Benefits of increasing age limit for Lynch syndrome genetic testing AS Sie PharmacoEconomics & Outcomes News 709, 3-16, 2014 | | 2014 |
Nicoline HoogerbruggeHoogleraar erfelijke kanker, medisch specialistVerified email at gen.umcn.nl
Nicoline HoogerbruggeHoogleraar erfelijke kanker, medisch specialistVerified email at gen.umcn.nl